|
2023-03-10 |
2023-03-10 |
K
Kauf
|
Sumitomo Chemical Co., Ltd.
Großaktionär
|
51.599.200
+889.5%
27,00
1.393.178.400 USD
|
51.599.200
+889.5%
|
27,00
|
1.393.178.400 USD
|
|
|
2023-01-20 |
2023-01-18 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
1.109
-0.4%
26,89
29.821 USD
|
1.109
-0.4%
|
26,89
|
29.821 USD
|
|
|
2023-01-20 |
2023-01-18 |
V
Verkauf
|
Merendino Lauren
Chief Commercial Officer
Führungsperson
|
2.008
-1.2%
26,89
53.995 USD
|
2.008
-1.2%
|
26,89
|
53.995 USD
|
|
|
2023-01-20 |
2023-01-18 |
V
Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
1.272
-0.4%
26,89
34.204 USD
|
1.272
-0.4%
|
26,89
|
34.204 USD
|
|
|
2023-01-20 |
2023-01-18 |
V
Verkauf
|
Marek David C
Principal Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
8.037
-1.9%
26,89
216.115 USD
|
8.037
-1.9%
|
26,89
|
216.115 USD
|
|
|
2023-01-05 |
2023-01-04 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
2.251
-0.9%
26,90
60.552 USD
|
2.251
-0.9%
|
26,90
|
60.552 USD
|
|
|
2023-01-05 |
2023-01-04 |
V
Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
2.779
-0.8%
26,90
74.755 USD
|
2.779
-0.8%
|
26,90
|
74.755 USD
|
|
|
2022-12-20 |
2022-12-16 |
V
Verkauf
|
Mehra Uneek
Principal Financial Officer
Führungsperson
|
2.241
-1.1%
26,75
59.947 USD
|
2.241
-1.1%
|
26,75
|
59.947 USD
|
|
|
2022-10-20 |
2022-10-18 |
V
Verkauf
|
Marek David C
Principal Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
11.156
-2.6%
25,20
281.131 USD
|
11.156
-2.6%
|
25,20
|
281.131 USD
|
|
|
2022-10-20 |
2022-10-18 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
1.604
-0.6%
25,20
40.421 USD
|
1.604
-0.6%
|
25,20
|
40.421 USD
|
|
|
2022-10-20 |
2022-10-18 |
V
Verkauf
|
Merendino Lauren
Chief Commercial Officer
Führungsperson
|
1.703
-1.0%
25,20
42.916 USD
|
1.703
-1.0%
|
25,20
|
42.916 USD
|
|
|
2022-10-20 |
2022-10-18 |
V
Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
1.933
-0.5%
25,20
48.712 USD
|
1.933
-0.5%
|
25,20
|
48.712 USD
|
|
|
2022-10-06 |
2022-10-04 |
V
Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
3.679
-1.0%
24,40
89.768 USD
|
3.679
-1.0%
|
24,40
|
89.768 USD
|
|
|
2022-10-06 |
2022-10-04 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
2.738
-1.1%
24,40
66.807 USD
|
2.738
-1.1%
|
24,40
|
66.807 USD
|
|
|
2022-09-20 |
2022-09-16 |
V
Verkauf
|
Mehra Uneek
Principal Financial Officer
Führungsperson
|
9.243
-4.3%
18,86
174.323 USD
|
9.243
-4.3%
|
18,86
|
174.323 USD
|
|
|
2022-08-16 |
2022-08-15 |
V
Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
31.214
-7.9%
18,23
569.031 USD
|
31.214
-7.9%
|
18,23
|
569.031 USD
|
|
|
2022-07-20 |
2022-07-18 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
1.606
-0.6%
12,87
20.669 USD
|
1.606
-0.6%
|
12,87
|
20.669 USD
|
|
|
2022-07-20 |
2022-07-18 |
V
Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
1.935
-0.7%
12,87
24.903 USD
|
1.935
-0.7%
|
12,87
|
24.903 USD
|
|
|
2022-07-20 |
2022-07-18 |
V
Verkauf
|
Merendino Lauren
Chief Commercial Officer
Führungsperson
|
1.704
-1.0%
12,87
21.930 USD
|
1.704
-1.0%
|
12,87
|
21.930 USD
|
|
|
2022-07-20 |
2022-07-18 |
V
Verkauf
|
Marek David C
Principal Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
11.164
-2.5%
12,87
143.681 USD
|
11.164
-2.5%
|
12,87
|
143.681 USD
|
|
|
2022-07-08 |
2022-07-06 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
2.755
-1.1%
13,40
36.917 USD
|
2.755
-1.1%
|
13,40
|
36.917 USD
|
|
|
2022-07-08 |
2022-07-06 |
V
Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
3.702
-1.3%
13,40
49.607 USD
|
3.702
-1.3%
|
13,40
|
49.607 USD
|
|
|
2022-06-01 |
2022-05-27 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
1.382
-0.5%
10,07
13.917 USD
|
1.382
-0.5%
|
10,07
|
13.917 USD
|
|
|
2022-04-21 |
2022-04-19 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
4.632
-1.7%
10,45
48.404 USD
|
4.632
-1.7%
|
10,45
|
48.404 USD
|
|
|
2022-04-21 |
2022-04-19 |
V
Verkauf
|
Merendino Lauren
Chief Commercial Officer
Führungsperson
|
7.049
-3.9%
10,45
73.662 USD
|
7.049
-3.9%
|
10,45
|
73.662 USD
|
|
|
2022-04-21 |
2022-04-19 |
V
Verkauf
|
Marek David C
Principal Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
24.594
-5.2%
10,45
257.007 USD
|
24.594
-5.2%
|
10,45
|
257.007 USD
|
|
|
2022-04-21 |
2022-04-19 |
V
Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
8.002
-2.8%
10,45
83.621 USD
|
8.002
-2.8%
|
10,45
|
83.621 USD
|
|
|
2022-04-07 |
2022-04-05 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
1.922
-1.2%
13,78
26.485 USD
|
1.922
-1.2%
|
13,78
|
26.485 USD
|
|
|
2022-04-07 |
2022-04-05 |
V
Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
2.436
-1.4%
13,78
33.568 USD
|
2.436
-1.4%
|
13,78
|
33.568 USD
|
|
|
2022-03-03 |
2022-03-01 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
1.362
-0.8%
13,35
18.183 USD
|
1.362
-0.8%
|
13,35
|
18.183 USD
|
|
|
2022-01-21 |
2022-01-19 |
V
Verkauf
|
Marek David C
Principal Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
19.882
-5.6%
14,68
291.868 USD
|
19.882
-5.6%
|
14,68
|
291.868 USD
|
|
|
2022-01-06 |
2022-01-04 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
2.271
-1.4%
16,27
36.949 USD
|
2.271
-1.4%
|
16,27
|
36.949 USD
|
|
|
2022-01-06 |
2022-01-04 |
V
Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
4.475
-2.5%
16,27
72.808 USD
|
4.475
-2.5%
|
16,27
|
72.808 USD
|
|
|
2021-12-01 |
2021-11-29 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
1.978
-1.2%
19,30
38.175 USD
|
1.978
-1.2%
|
19,30
|
38.175 USD
|
|
|
2021-11-05 |
2021-11-04 |
GV
Geplanter Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
3.100
-1.8%
24,02
74.462 USD
|
3.100
-1.8%
|
24,02
|
74.462 USD
|
|
|
2021-11-05 |
2021-11-03 |
GV
Geplanter Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
700
-0.4%
24,00
16.800 USD
|
700
-0.4%
|
24,00
|
16.800 USD
|
|
|
2021-10-07 |
2021-10-05 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
2.738
-1.6%
21,62
59.196 USD
|
2.738
-1.6%
|
21,62
|
59.196 USD
|
|
|
2021-10-07 |
2021-10-05 |
V
Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
6.671
-3.6%
21,62
144.227 USD
|
6.671
-3.6%
|
21,62
|
144.227 USD
|
|
|
2021-09-29 |
2021-09-27 |
GV
Geplanter Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
7.000
-3.9%
24,32
170.240 USD
|
7.000
-3.9%
|
24,32
|
170.240 USD
|
|
|
2021-09-28 |
2021-09-27 |
GK
Geplanter Kauf
|
Sumitomo Chemical Co., Ltd.
Großaktionär
|
2.232
+0.0%
24,86
55.486 USD
|
2.232
+0.0%
|
24,86
|
55.486 USD
|
|
|
2021-09-28 |
2021-09-27 |
GK
Geplanter Kauf
|
Sumitomo Chemical Co., Ltd.
Großaktionär
|
45.768
+0.1%
24,19
1.106.904 USD
|
45.768
+0.1%
|
24,19
|
1.106.904 USD
|
|
|
2021-09-28 |
2021-09-24 |
GK
Geplanter Kauf
|
Sumitomo Chemical Co., Ltd.
Großaktionär
|
36.000
+0.1%
23,40
842.548 USD
|
36.000
+0.1%
|
23,40
|
842.548 USD
|
|
|
2021-09-14 |
2021-09-13 |
GK
Geplanter Kauf
|
Sumitomo Chemical Co., Ltd.
Großaktionär
|
30.028
+0.1%
23,91
717.990 USD
|
30.028
+0.1%
|
23,91
|
717.990 USD
|
|
|
2021-09-14 |
2021-09-13 |
GK
Geplanter Kauf
|
Sumitomo Chemical Co., Ltd.
Großaktionär
|
53.150
+0.1%
23,09
1.227.058 USD
|
53.150
+0.1%
|
23,09
|
1.227.058 USD
|
|
|
2021-09-14 |
2021-09-10 |
GK
Geplanter Kauf
|
Sumitomo Chemical Co., Ltd.
Großaktionär
|
30.000
+0.1%
25,11
753.390 USD
|
30.000
+0.1%
|
25,11
|
753.390 USD
|
|
|
2021-09-13 |
2021-09-09 |
GV
Geplanter Verkauf
|
Curran Terrie
Nicht geschäftsführender Verwaltungsratsmitglied
|
4.850
-100.0%
25,58
124.063 USD
|
4.850
-100.0%
|
25,58
|
124.063 USD
|
|
|
2021-09-01 |
2021-08-31 |
GK
Geplanter Kauf
|
Sumitomo Chemical Co., Ltd.
Großaktionär
|
39.000
+0.1%
24,28
946.885 USD
|
39.000
+0.1%
|
24,28
|
946.885 USD
|
|
|
2021-09-01 |
2021-08-30 |
GK
Geplanter Kauf
|
Sumitomo Chemical Co., Ltd.
Großaktionär
|
70.000
+0.1%
23,92
1.674.099 USD
|
70.000
+0.1%
|
23,92
|
1.674.099 USD
|
|
|
2021-08-30 |
2021-08-27 |
GK
Geplanter Kauf
|
Sumitomo Chemical Co., Ltd.
Großaktionär
|
37.038
+0.1%
23,17
858.252 USD
|
37.038
+0.1%
|
23,17
|
858.252 USD
|
|
|
2021-08-30 |
2021-08-26 |
GK
Geplanter Kauf
|
Sumitomo Chemical Co., Ltd.
Großaktionär
|
40.000
+0.1%
22,67
906.912 USD
|
40.000
+0.1%
|
22,67
|
906.912 USD
|
|
|
2021-08-20 |
2021-08-19 |
GK
Geplanter Kauf
|
Sumitomo Chemical Co., Ltd.
Großaktionär
|
46.792
+0.1%
21,51
1.006.421 USD
|
46.792
+0.1%
|
21,51
|
1.006.421 USD
|
|
|
2021-08-20 |
2021-08-18 |
GK
Geplanter Kauf
|
Sumitomo Chemical Co., Ltd.
Großaktionär
|
17.116
+0.0%
21,45
367.092 USD
|
17.116
+0.0%
|
21,45
|
367.092 USD
|
|
|
2021-06-02 |
2021-05-28 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
1.783
-1.0%
24,00
42.792 USD
|
1.783
-1.0%
|
24,00
|
42.792 USD
|
|
|
2021-06-02 |
2021-05-28 |
GV
Geplanter Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
1.300
-0.7%
24,00
31.200 USD
|
1.300
-0.7%
|
24,00
|
31.200 USD
|
|
|
2021-05-28 |
2021-05-26 |
GV
Geplanter Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
12.700
-6.7%
24,23
307.721 USD
|
12.700
-6.7%
|
24,23
|
307.721 USD
|
|
|
2021-04-08 |
2021-04-06 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
8.114
-6.0%
18,63
151.164 USD
|
8.114
-6.0%
|
18,63
|
151.164 USD
|
|
|
2021-04-08 |
2021-04-06 |
V
Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
10.862
-7.4%
18,62
202.250 USD
|
10.862
-7.4%
|
18,62
|
202.250 USD
|
|
|
2021-03-23 |
2021-03-19 |
GV
Geplanter Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
7.000
-4.9%
24,17
169.190 USD
|
7.000
-4.9%
|
24,17
|
169.190 USD
|
|
|
2021-03-17 |
2021-03-15 |
GV
Geplanter Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
30.000
-17.1%
25,07
752.013 USD
|
30.000
-17.1%
|
25,07
|
752.013 USD
|
|
|
2021-03-03 |
2021-03-01 |
V
Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
1.513
-1.1%
22,55
34.118 USD
|
1.513
-1.1%
|
22,55
|
34.118 USD
|
|
|
2021-02-18 |
2021-02-16 |
GV
Geplanter Verkauf
|
KARBE FRANK
Principal Fin'l & Accounting
Führungsperson
|
750
-0.5%
21,40
16.050 USD
|
750
-0.5%
|
21,40
|
16.050 USD
|
|
|
2021-02-01 |
2021-01-28 |
GV
Geplanter Verkauf
|
KARBE FRANK
Principal Fin'l & Accounting
Führungsperson
|
300
-0.2%
24,00
7.200 USD
|
300
-0.2%
|
24,00
|
7.200 USD
|
|
|
2021-01-20 |
2021-01-15 |
GV
Geplanter Verkauf
|
KARBE FRANK
Principal Fin'l & Accounting
Führungsperson
|
750
-0.5%
21,50
16.125 USD
|
750
-0.5%
|
21,50
|
16.125 USD
|
|
|
2020-12-30 |
2020-12-28 |
GV
Geplanter Verkauf
|
KARBE FRANK
Principal Fin'l & Accounting
Führungsperson
|
11.800
-6.7%
30,00
354.000 USD
|
11.800
-6.7%
|
30,00
|
354.000 USD
|
|
|
2020-12-22 |
2020-12-18 |
GV
Geplanter Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
2.000
-1.4%
26,00
52.000 USD
|
2.000
-1.4%
|
26,00
|
52.000 USD
|
|
|
2020-12-22 |
2020-12-18 |
GV
Geplanter Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
300
-0.2%
26,24
7.871 USD
|
300
-0.2%
|
26,24
|
7.871 USD
|
|
|
2020-12-22 |
2020-12-18 |
GV
Geplanter Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
9.700
-6.2%
25,38
246.183 USD
|
9.700
-6.2%
|
25,38
|
246.183 USD
|
|
|
2020-12-17 |
2020-12-15 |
GV
Geplanter Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
3.467
-2.5%
24,18
83.837 USD
|
3.467
-2.5%
|
24,18
|
83.837 USD
|
|
|
2020-12-17 |
2020-12-15 |
GV
Geplanter Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
3.533
-2.5%
23,66
83.589 USD
|
3.533
-2.5%
|
23,66
|
83.589 USD
|
|
|
2020-12-17 |
2020-12-15 |
GV
Geplanter Verkauf
|
KARBE FRANK
Principal Fin'l & Accounting
Führungsperson
|
670
-0.4%
24,45
16.383 USD
|
670
-0.4%
|
24,45
|
16.383 USD
|
|
|
2020-12-17 |
2020-12-15 |
GV
Geplanter Verkauf
|
KARBE FRANK
Principal Fin'l & Accounting
Führungsperson
|
380
-0.2%
23,63
8.980 USD
|
380
-0.2%
|
23,63
|
8.980 USD
|
|
|
2020-12-14 |
2020-12-10 |
GV
Geplanter Verkauf
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Führungsperson
|
10.000
-6.8%
26,04
260.362 USD
|
10.000
-6.8%
|
26,04
|
260.362 USD
|
|
|
2020-12-11 |
2020-12-10 |
GV
Geplanter Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
19.400
-11.7%
25,20
488.783 USD
|
19.400
-11.7%
|
25,20
|
488.783 USD
|
|
|
2020-12-11 |
2020-12-09 |
GV
Geplanter Verkauf
|
Lang Matthew
General Counsel & Corp. Secy.
Führungsperson
|
600
-0.4%
25,08
15.049 USD
|
600
-0.4%
|
25,08
|
15.049 USD
|
|
|
2020-12-02 |
2020-11-30 |
GV
Geplanter Verkauf
|
KARBE FRANK
Principal Fin'l & Accounting
Führungsperson
|
1.500
-0.9%
24,00
36.000 USD
|
1.500
-0.9%
|
24,00
|
36.000 USD
|
|
